Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Escribano

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Sangre|January 1, 1972
[Acute leukemia in adolescents and adults: data of prognostic value]J M Montero García, A D Pérez-Navarro, J A Noriega Marcos, et al.
Leukemia|February 16, 2016
Complete response to gemtuzumab ozogamicin in a patient with refractory mast cell leukemiaI Alvarez-Twose, P Martínez-Barranco, J Gotlib, et al.
Allergy|January 14, 2018
Characterization of CD34<sup>+</sup> hematopoietic cells in systemic mastocytosis: Potential role in disease disseminationA Mayado, C Teodosio, N Dasilva-Freire, et al.
Leukemia|July 9, 2015
Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progressionA Mayado, C Teodosio, A C Garcia-Montero, et al.
Seminars in Oncology|April 30, 2003
Immunophenotypic analysis of Waldenstrom's macroglobulinemiaJ F San Miguel, M B Vidriales, E Ocio, et al.
Cytometry. Part B, Clinical Cytometry|April 27, 2011
Evaluation of basophil activation in mastocytosis with Hymenoptera venom anaphylaxisD González-de-Olano, I Alvarez-Twose, J M Morgado, et al.
Haematologica|December 20, 1999
Stage, percentage of basophils at diagnosis, hematologic response within six months, cytogenetic response in the first year: the main prognostic variables affecting outcome in patients with chronic myeloid leukemia in chronic phase treated with interferon-alpha. Results of the CML89 trial of the Spanish Collaborative Group on interferon-alpha2a and CMLJ L Steegmann, J Odriozola, F Rodriguez-Salvanés, et al.
Journal of Investigational Allergology & Clinical Immunology|March 25, 2014
Recommendations for the use of in vitro methods to detect specific immunoglobulin E: are they comparable?M J Goikoetxea, M L Sanz, B E García, et al.
Revista De Neurologia|July 11, 1998
[Gamma-sarcoglycanopathy: clinico-pathological and genetic study of 11 cases]D García-García, S Teijeira-Bautista, J M Fernández-Rodríguez, et al.
Leukemia Research|May 30, 2001
Diagnostic criteria and classification of mastocytosis: a consensus proposalP Valent, H P Horny, L Escribano, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Sangre|January 1, 1972
[Acute leukemia in adolescents and adults: data of prognostic value]J M Montero García, A D Pérez-Navarro, J A Noriega Marcos, et al.
Leukemia|February 16, 2016
Complete response to gemtuzumab ozogamicin in a patient with refractory mast cell leukemiaI Alvarez-Twose, P Martínez-Barranco, J Gotlib, et al.
Allergy|January 14, 2018
Characterization of CD34<sup>+</sup> hematopoietic cells in systemic mastocytosis: Potential role in disease disseminationA Mayado, C Teodosio, N Dasilva-Freire, et al.
Leukemia|July 9, 2015
Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progressionA Mayado, C Teodosio, A C Garcia-Montero, et al.
Seminars in Oncology|April 30, 2003
Immunophenotypic analysis of Waldenstrom's macroglobulinemiaJ F San Miguel, M B Vidriales, E Ocio, et al.
Cytometry. Part B, Clinical Cytometry|April 27, 2011
Evaluation of basophil activation in mastocytosis with Hymenoptera venom anaphylaxisD González-de-Olano, I Alvarez-Twose, J M Morgado, et al.
Haematologica|December 20, 1999
Stage, percentage of basophils at diagnosis, hematologic response within six months, cytogenetic response in the first year: the main prognostic variables affecting outcome in patients with chronic myeloid leukemia in chronic phase treated with interferon-alpha. Results of the CML89 trial of the Spanish Collaborative Group on interferon-alpha2a and CMLJ L Steegmann, J Odriozola, F Rodriguez-Salvanés, et al.
Journal of Investigational Allergology & Clinical Immunology|March 25, 2014
Recommendations for the use of in vitro methods to detect specific immunoglobulin E: are they comparable?M J Goikoetxea, M L Sanz, B E García, et al.
Revista De Neurologia|July 11, 1998
[Gamma-sarcoglycanopathy: clinico-pathological and genetic study of 11 cases]D García-García, S Teijeira-Bautista, J M Fernández-Rodríguez, et al.
Leukemia Research|May 30, 2001
Diagnostic criteria and classification of mastocytosis: a consensus proposalP Valent, H P Horny, L Escribano, et al.
Pageof 11